ASCERT subanalysis compares procedural costs over long term

11/12/2012 | TCTMD.com

At every point measured, bypass surgery was more expensive than percutaneous coronary intervention, even though CABG demonstrated cost-effectiveness over the longer term, according to a subanalysis of the ASCERT trial reported in the New England Journal of Medicine and discussed at the annual meeting of the American Heart Association. Session co-moderator Dr. Ralph Brindis said many concerns must be taken into account when treatment decisions are made: "As we [care for] the patient, we have to not only think about issues of quality, but accountability, transparency and cost."

View Full Article in:

TCTMD.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA